Tang Capital Management as of June 30, 2023
Portfolio Holdings for Tang Capital Management
Tang Capital Management holds 99 positions in its portfolio as reported in the June 2023 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Anaptysbio Inc Common (ANAB) | 5.8 | $40M | 2.0M | 20.34 | |
Tarsus Pharmaceuticals (TARS) | 4.7 | $32M | 1.8M | 18.07 | |
Mirum Pharmaceuticals (MIRM) | 4.3 | $29M | 1.1M | 25.87 | |
ImmunoGen | 3.6 | $25M | 1.3M | 18.87 | |
Immunocore Hldgs Ads (IMCR) | 3.6 | $24M | 406k | 59.96 | |
Bluebird Bio (BLUE) | 3.6 | $24M | 7.4M | 3.29 | |
Kalvista Pharmaceuticals (KALV) | 3.5 | $24M | 2.7M | 9.00 | |
Axsome Therapeutics (AXSM) | 3.4 | $23M | 320k | 71.86 | |
Evolus (EOLS) | 3.3 | $23M | 3.1M | 7.27 | |
Intra Cellular Therapies (ITCI) | 2.8 | $19M | 300k | 63.32 | |
New York Community Ban | 2.7 | $18M | 1.6M | 11.24 | |
BioCryst Pharmaceuticals (BCRX) | 2.5 | $17M | 2.5M | 7.04 | |
Miragen Therapeutics (VRDN) | 2.4 | $17M | 693k | 23.79 | |
Beigene Sponsored Adr (BGNE) | 2.2 | $15M | 85k | 178.30 | |
Vaxcyte (PCVX) | 2.2 | $15M | 300k | 49.94 | |
Eli Lilly & Co. (LLY) | 2.1 | $14M | 30k | 468.98 | |
Inflarx Nv (IFRX) | 1.9 | $13M | 2.9M | 4.46 | |
Astrazeneca Sponsored Adr (AZN) | 1.8 | $12M | 170k | 71.57 | |
Cytomx Therapeutics (CTMX) | 1.7 | $11M | 6.6M | 1.72 | |
Atea Pharmaceuticals (AVIR) | 1.7 | $11M | 3.0M | 3.74 | |
Bioatla (BCAB) | 1.6 | $11M | 3.7M | 3.00 | |
Altimmune Com New (ALT) | 1.4 | $9.7M | 2.8M | 3.53 | |
Harmony Biosciences Hldgs In (HRMY) | 1.4 | $9.5M | 271k | 35.19 | |
Zymeworks Del (ZYME) | 1.4 | $9.5M | 1.1M | 8.64 | |
Moderna (MRNA) | 1.4 | $9.3M | 77k | 121.50 | |
Capital One Financial (COF) | 1.3 | $8.7M | 80k | 109.37 | |
Third Harmonic Bio (THRD) | 1.3 | $8.7M | 1.8M | 4.81 | |
Verastem Com New (VSTM) | 1.2 | $8.5M | 1.1M | 7.44 | |
Amarin Corp Spons Adr New (AMRN) | 1.2 | $8.4M | 7.1M | 1.19 | |
Kiniksa Pharmaceuticals Com Cl A | 1.2 | $8.4M | 600k | 14.08 | |
Ionis Pharmaceuticals (IONS) | 1.2 | $8.2M | 200k | 41.03 | |
Elevation Oncology (ELEV) | 0.9 | $6.1M | 4.0M | 1.52 | |
Bio Rad Labs Cl A (BIO) | 0.9 | $6.1M | 16k | 379.12 | |
Adicet Bio (ACET) | 0.9 | $6.0M | 2.5M | 2.43 | |
Cortexyme (QNCX) | 0.8 | $5.4M | 3.6M | 1.50 | |
Graphite Bio | 0.8 | $5.4M | 2.1M | 2.60 | |
Cullinan Oncology (CGEM) | 0.7 | $4.8M | 450k | 10.76 | |
Adma Biologics (ADMA) | 0.7 | $4.6M | 1.3M | 3.69 | |
Citigroup Com New (C) | 0.7 | $4.6M | 100k | 46.04 | |
Magenta Therapeutics | 0.7 | $4.6M | 6.1M | 0.76 | |
Pyxis Oncology Common Stock (PYXS) | 0.7 | $4.6M | 1.8M | 2.56 | |
Adaptimmune Therapeutics Sponds Adr (ADAP) | 0.7 | $4.5M | 4.9M | 0.93 | |
Rain Therapeutics | 0.7 | $4.5M | 3.7M | 1.20 | |
Genfit S A Ads (GNFT) | 0.6 | $4.4M | 1.2M | 3.54 | |
Bolt Biotherapeutics (BOLT) | 0.6 | $4.3M | 3.3M | 1.28 | |
Enzo Biochem (ENZ) | 0.6 | $4.2M | 2.3M | 1.84 | |
Novocure Ord Shs (NVCR) | 0.6 | $4.2M | 100k | 41.50 | |
Aslan Pharmaceuticals Spon Ads New (ASLN) | 0.6 | $4.1M | 1.1M | 3.65 | |
Dynavax Technologies Corp Com New (DVAX) | 0.6 | $3.9M | 300k | 12.92 | |
Veritex Hldgs (VBTX) | 0.6 | $3.8M | 210k | 17.93 | |
Galapagos Nv Spon Adr (GLPG) | 0.5 | $3.6M | 90k | 40.66 | |
Phathom Pharmaceuticals (PHAT) | 0.5 | $3.6M | 250k | 14.32 | |
Pardes Biosciences | 0.5 | $3.5M | 1.9M | 1.81 | |
Insmed Com Par $.01 (INSM) | 0.5 | $3.5M | 166k | 21.10 | |
Biohaven (BHVN) | 0.5 | $3.3M | 140k | 23.92 | |
Fate Therapeutics (FATE) | 0.5 | $3.3M | 700k | 4.76 | |
Us Bancorp Del Com New (USB) | 0.5 | $3.3M | 100k | 33.04 | |
Aligos Therapeutics (ALGS) | 0.5 | $3.2M | 3.3M | 0.97 | |
Nkarta (NKTX) | 0.4 | $3.0M | 1.4M | 2.19 | |
Mirati Therapeutics | 0.4 | $2.9M | 80k | 36.13 | |
Silverback Therapeutics (SPRY) | 0.4 | $2.7M | 410k | 6.70 | |
CVB Financial (CVBF) | 0.4 | $2.7M | 200k | 13.28 | |
Esperion Therapeutics (ESPR) | 0.4 | $2.6M | 1.9M | 1.39 | |
Avrobio Ord (AVRO) | 0.4 | $2.6M | 2.7M | 0.95 | |
2seventy Bio Common Stock (TSVT) | 0.4 | $2.5M | 250k | 10.12 | |
Mei Pharma (MEIP) | 0.3 | $2.4M | 361k | 6.58 | |
Eagle Pharmaceuticals (EGRX) | 0.3 | $2.3M | 119k | 19.44 | |
Lianbio Sponsored Ads (LIANY) | 0.3 | $2.2M | 962k | 2.28 | |
Amylyx Pharmaceuticals (AMLX) | 0.3 | $2.2M | 100k | 21.57 | |
Bankunited (BKU) | 0.3 | $2.2M | 100k | 21.55 | |
Heron Therapeutics (HRTX) | 0.3 | $2.1M | 1.9M | 1.16 | |
Equity Comwlth Com Sh Ben Int (EQC) | 0.3 | $2.0M | 100k | 20.26 | |
Arvinas Ord (ARVN) | 0.3 | $2.0M | 80k | 24.82 | |
Coherus Biosciences (CHRS) | 0.3 | $1.7M | 400k | 4.27 | |
Editas Medicine (EDIT) | 0.2 | $1.6M | 200k | 8.23 | |
Aurinia Pharmaceuticals (AUPH) | 0.2 | $1.5M | 150k | 9.68 | |
Bank of Hawaii Corporation (BOH) | 0.2 | $1.2M | 30k | 41.23 | |
Servisfirst Bancshares (SFBS) | 0.2 | $1.2M | 30k | 40.92 | |
Adagio Therapeutics (IVVD) | 0.2 | $1.2M | 1.2M | 1.05 | |
Crispr Therapeutics Namen Akt (CRSP) | 0.2 | $1.1M | 20k | 56.14 | |
Athira Pharma (ATHA) | 0.2 | $1.0M | 353k | 2.95 | |
Inspirato Incorporated Com Cl A | 0.1 | $1.0M | 1.0M | 0.98 | |
Ascendis Pharma A/s Sponsored Adr (ASND) | 0.1 | $893k | 10k | 89.25 | |
Nextcure (NXTC) | 0.1 | $720k | 400k | 1.80 | |
908 Devices (MASS) | 0.1 | $686k | 100k | 6.86 | |
Tango Therapeutics (TNGX) | 0.1 | $664k | 200k | 3.32 | |
Pds Biotechnology Ord (PDSB) | 0.1 | $503k | 100k | 5.03 | |
Stellar Bancorp Ord (STEL) | 0.1 | $458k | 20k | 22.89 | |
Selecta Biosciences | 0.1 | $448k | 400k | 1.12 | |
Neuronetics (STIM) | 0.1 | $430k | 200k | 2.15 | |
Genedx Holdings Corp Com Cl A (WGS) | 0.1 | $379k | 64k | 5.96 | |
Atyr Pharma Com New (ATYR) | 0.0 | $324k | 150k | 2.16 | |
Equillium (EQ) | 0.0 | $300k | 400k | 0.75 | |
Passage Bio (PASG) | 0.0 | $282k | 300k | 0.94 | |
Freeline Therapeutics Hldgs Sponsored Ads | 0.0 | $258k | 100k | 2.58 | |
Molecular Partners Ads (MOLN) | 0.0 | $247k | 40k | 6.22 | |
Acelrx Pharmaceuticals Com New (TLPH) | 0.0 | $217k | 195k | 1.11 | |
China Recycling Energy Corp (CREG) | 0.0 | $203k | 125k | 1.62 | |
Nektar Therapeutics (NKTR) | 0.0 | $80k | 140k | 0.58 |